◆ 会议时间：2023年4月15-18日
◆ 会议地点：丹麦 哥本哈根

◆ 会议简介：

2023年第33届欧洲临床微生物与传染病学大会(ECCMID2023)将于2023年4月15-18日在丹麦哥本哈根举行，会议由欧洲临床微生物学与感染病学会（ESCMID）主办。ECCMID是临床微生物学、感染性疾病和感染控制领域规模最大、内容最全面、最具影响力的国际会议，汇集了来自众多领域的国际专家，向14000多名来自世界各地的同行介绍他们的最新发现、指南和经验；大会将利用最新的技术呈现最科学的教育计划，包括主题演讲、座谈会、海报会议、教育研讨会、专家会面、展览会等多种形式。

欧洲临床微生物和感染病学会(ESCMID)成立于1983年，是一个致力于通过促进研究、教育、培训、医疗实践提高感染相关疾病的诊断、治疗和预防水平的非营利组织，是欧洲领先的临床微生物学和感染病学会宣。30多年来，ESCMID已经成微生物学家和感染病专家职业生涯最有影响力的组成部分，现在世界各地拥有7000多名个人会员和30,000余名附属成员（未经本站许可禁止复制摘录转载本站任何内容-领域国际医学会议网(lingyuint.com)

ESCMID于每年春季举办欧洲临床微生物与感染病学大会(ECCMID)，ECCMID是学术界、临床研究机构和业界公认的欧洲最大的分析和讨论临床微生物学和感染病学研究的大会。ECCMID最初每两年召开一次，1999年成为一年一度的盛会。近年来，ECCMID的规模和地位不断提升，现在每年吸引约10,000名参与者，提交的摘要数量已增加到3,000多个，其中65％被接受为口头或海报展示。

ECCMID 2023 - 33rd European Congress of Clinical Microbiology & Infectious Disease
Date: 15 - 18 April 2023
Location: BELLA CENTER COPENHAGEN (Copenhagen, Denmark)

ECCMID, as the world’s premier Clinical Microbiology & Infectious Diseases event, brings together experts from many fields to present their latest findings, guidelines and experiences to an audience of over 13,000 colleagues. This year, the Programme Committee has developed a multi-faceted program incorporating keynote lectures and oral sessions, as well as interactive workshops, meet-the-expert sessions, open forums, and a wide range of symposia. Be sure to get involved in all of the exciting educational, social and professional events ECCMID has to offer you!

摘要征文投稿重要日期：

Regular abstracts

• Submission: 17 October - 30 November 2022
• Review: December/January 2022/2023
• Notification to the abstract submitters: Early February 2023

点此提交摘要>>>Submit Abstract>>>

Case report/series

For a case report/series (featuring a single instructive case or a series of up to 10 cases),  emphasise the unique aspects of the case(s) and discuss learning points emerging from the case(s). The ECCMID Programme Committee will review and select abstracts to be presented at ECCMID 2023 during Case sessions or as paper posters and/or ePosters.

• Submission: 17 October - 30 November 2022
• Review: December/January 2022/2023
• Notification to the abstract submitters: Early February 2023

CGR cases

For an instructive case to be presented during the prestigious ECCMID 2023 CGR session. The ECCMID Programme Committee will review the abstracts for the CGR session selection.

• Submission: 1 - 20 December 2022
• Review: Late December 2022
• Notification to the abstract submitters: Early January 2023

Important: Abstracts not selected for CGR session will be included in the review with Case report abstracts submitted for ECCMID 2023.

TAE Research Bites – new at ECCMID 2023!!!

For novel data that has not been previously presented or published. The submission is reserved for the ESCMID Young Scientist Member enrolled in CM ID/IC training or a PhD programme who want to increase their chances of being selected for an oral presentation. ESCMID TAE and SAS members will select abstracts to be presented at ECCMID 2023 during the TAE Research Bites session.

• Submission: 17 October - 16 November 2022
• Review: 17 November - 30 November 2022
• Notification to the abstract submitters: Early December 2022

Important:Abstracts not selected for the Research Bites session will be included in the review with Regular abstracts submitted for ECCMID 2023.

提交指南：

Abstract type

Abstracts should fall into one of four selectable categories:

1. Regular abstract
2. Case report/series
3. CGR cases
4. TAE Research Bites

If ‘Case report/ series’ or ’CGR cases’ is selected, the template sections:

Background/Materials/Results/ Conclusions will be automatically replaced by the sections:

Background/Case(s) description/ Discussion

Authors

If the submitter is a co-author of the abstract, we kindly ask you to include this information on the co-author list.

Please double check correct spelling and formatting of the author(s) names and affiliation(s).

Please use appropriate capitalisation and punctuation.             

Please note that the submitter cannot edit names and affiliations once the submission is completed.

ESCMID takes no responsibility for errors in either author or affiliation information.

Text

ALL CAPS for text (other than abbreviations or acronyms) are not allowed. The abstract text cannot be longer than 350 words.

Title

Abstract title should be concise and must be submitted in line with scientific rules. This applies to special characters and words that need to be CAPITALISED or italicised.

Please DO NOT capitalise title except first word, DO NOT use a dot to finish title.

Please DO NOT use any brand names in the title. ESCMID reserves rights to proof and adjust titles according to ESCMID guidelines format without consent of the author

Abstract body

Use the provided fields to draft your abstract. The text of the entire abstract must not exceed 350 words (word count includes title, excluding figure descriptions). Please ensure that different sections of your abstract are entered into the appropriate textbox. For research abstracts, briefly state the background, context of research, and its goals.

The methods section should provide minimum required information on the research setting, data collection, and analytical methods.

The results presented in the abstract should be original, not published or presented previously.

For case report/series and CGR cases (usually featuring a single instructive case or a series of up to 10 cases) emphasise the unique aspects of the case and discuss the learning points emerging from the case(s).

Reviews only or abstracts without data content cannot be accepted.

Pictures/Graphs/Tables

Please use the figure upload fields at the bottom to select up to 3 images. Figure sections can be used to upload images, graphs, or tables.

Accepted formats: JPEG or PNG. Size: 1000x1000 pixels max. File size: up to 5 MB. Images larger than provided dimensions will be automatically resized to an A4 format in your submission confirmation.

Please double-check the readability of uploaded materials before submitting your abstract.

Spelling guidelines

Use British English spelling throughout. The International System of Units (SI) should be used wherever appropriate. Genus and species names should be written in full as the first mentioned and abbreviated subsequently.

The following scientific rules apply (examples in brackets):

• Systematic names (genus, family, and higher orders): capitalized (e.g., Chlamydia, Enterobacterales Picornaviridae)
• Non-English expressions in English texts are written in italics (e.g., in vitro/in vivo, ad hoc, ex officio)
• Taxonomic names must be italicised (e.g., Staphylococcus aureus, Clostridium difficile)
• Non-systematic names (e.g., plural): lower case and not italicized (group A streptococci, mycobacteria)
• Generic drug names: lower case (e.g, penicillin)
• Do not use brand names in titles: product names are allowed in the abstract text, but must be avoided in the title
• Please follow standard English grammar rules including a space after full stops and commas
• Only common abbreviations may be used without definition

Abstract topics

The full list of abstract topics may be found here.

Please choose the best-fitting abstract topic to ensure a sound and fair review by the most suitable reviewing expert.

It is possible (but not mandatory), specify a second category, if you feel that your abstract does not fit within a single category.

All case and case series abstracts will be automatically assigned to the category 13. Cases

Keywords

Authors are asked to enter three keywords to better define the abstract content.

Submit your abstract

You can save your abstract at any time. Please make sure to fill all fields correctly before final submission. Changes in the abstract are not possible after submission. After submission, a confirmation by email will be sent to the submitter (please make sure to state your correct email address!). All co-authors will be notified by email and will receive a copy of the submitted abstract. The submitter is responsible for obtaining permission for submission and presentation of the abstract from all co-authors and any relevant stakeholders. All correspondence regarding acceptance or rejection, including further information on the mode of presentation etc. will be sent to the presenting author. In case an abstract will be rejected as an oral presentation, its possibility to be accepted as a poster still remains. If so, the authors will be informed via e-mail.

Should you decide to change the type of abstract once you have started the submission, please withdraw your current abstract and re-start the submission process with new content.

注册费：

All prices are NOT subject to VAT.

* Young physician / scientist: for individuals 35 years of age or younger and for those under 40 years of age upon proof of training status (copy of passport and written confirmation of head of department obligatory)

** Student: copy of student ID required (English language)

*** Nurse / MLA: proof (employment status) required (English language)

**** As per the ESCMID low-income country membership definition (If this applies to you, please contact eccmidinfo[at]escmid.org to obtain this registration)

***** Day Tickets are available as from 15 April 2023 (only onsite and only if appropriate) and do not include public transportation passes.

• Admission to all scientific sessions
• Admission to the industrial exhibition
• Congress bag*
• Public transport within the city of Copenhagen (not included for exhibitors, exhibition visitors and day tickets)*

*Only applicable for onsite participation

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。